Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Pathogens

    Study Reveals Highjacked Genetic Regulators in Influenza Viruses

    By Global Biodefense StaffMarch 30, 2012
    Share
    Facebook LinkedIn Reddit Email

    In a study published this week in the Journal of Virology, University of British Columbia researchers identified a number of tiny but powerful genetic regulators that are hijacked by avian and swine flu viruses during human infection.

    The study is the first to compare the role played by human microRNAs, or small molecules that control the expression of multiple genes, in the life cycle of two influenza viruses. The research discovered two largely distinct sets of microRNAs involved in pandemic (2009) swine-origin H1N1 virus and the highly pathogenic avian-origin H7N7 strain, with only a small subset of microRNAs involved in the regulation of both infections.

    “We know that microRNAs are implicated in many types of cancers and other human diseases, but focusing on microRNA signatures in viral infection breaks new ground,” says François Jean, Associate Professor in the Department of Microbiology and Immunology and Scientific Director of the Facility for Infectious Disease and Epidemic Research (FINDER) at UBC.

    “Host-virus interplays are certainly complex, but our discovery points to a new level of cross-communication between viruses and the human cells in which they reproduce,” notes Jean. “The finding that a significant number of these microRNAs are transported in microparticles – known as exosomes –involved in intercellular communication is also very exciting. It raises the question as to what role these exosome-associated regulators may play in the onset and spread of the flu virus.”

    The researchers believes that the discovery of the unique microRNA signatures associated with pandemic and deadly influenza viruses will assist in developing novel antiviral treatments that do not contribute to increased drug resistance.

    The project was supported by the Canadian Institutes of Health Research and the Public Health Agency of Canada.

    Antivirals Avian Influenza Influenza
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleAir Force Office of Scientific Research BAA
    Next Article Environmental Response Laboratory Network RFQ

    Related Stories

    New Method Improves Quantification of Ricin in Complex Matrices

    September 20, 2023

    Healthcare Workers Express Outrage at Flawed CDC Mask Guidance

    September 18, 2023

    Mass Spec for Rapid Detection of Biological Warfare Agents

    September 15, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.